Alsharoh, H.; Chiroi, P.; Isachesku, E.; Tanasa, R.A.; Pop, O.-L.; Pirlog, R.; Berindan-Neagoe, I.
Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer. Biomedicines 2024, 12, 1489.
https://doi.org/10.3390/biomedicines12071489
AMA Style
Alsharoh H, Chiroi P, Isachesku E, Tanasa RA, Pop O-L, Pirlog R, Berindan-Neagoe I.
Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer. Biomedicines. 2024; 12(7):1489.
https://doi.org/10.3390/biomedicines12071489
Chicago/Turabian Style
Alsharoh, Hasan, Paul Chiroi, Ekaterina Isachesku, Radu Andrei Tanasa, Ovidiu-Laurean Pop, Radu Pirlog, and Ioana Berindan-Neagoe.
2024. "Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer" Biomedicines 12, no. 7: 1489.
https://doi.org/10.3390/biomedicines12071489
APA Style
Alsharoh, H., Chiroi, P., Isachesku, E., Tanasa, R. A., Pop, O.-L., Pirlog, R., & Berindan-Neagoe, I.
(2024). Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer. Biomedicines, 12(7), 1489.
https://doi.org/10.3390/biomedicines12071489